美敦力宣布与飞利浦建立战略合作伙伴关系，以扩大患者监测技术的使用范围Medtronic announces strategic partnership with Philips to expand access to patient monitoring technology

动脉网2025-07-01

Medtronic and Philips, two global leaders in healthcare technology, announced a significant step forward in their strategic collaboration in patient monitoring, signing a multi-year partnership ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2548023640?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-01 21:31","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2548023640","market":"us","top_or_hot":-1,"title":"美敦力宣布与飞利浦建立战略合作伙伴关系，以扩大患者监测技术的使用范围Medtronic announces strategic partnership with Philips to expand access to patient monitoring technology","media":"动脉网","content":"<div>\n<p>Medtronic and Philips, two global leaders in healthcare technology, announced a significant step forward in their strategic collaboration in patient monitoring, signing a multi-year partnership ...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070121342395329df8&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>美敦力宣布与飞利浦建立战略合作伙伴关系，以扩大患者监测技术的使用范围Medtronic announces strategic partnership with Philips to expand access to patient monitoring technology</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美敦力宣布与飞利浦建立战略合作伙伴关系，以扩大患者监测技术的使用范围Medtronic announces strategic partnership with Philips to expand access to patient monitoring technology\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-01 21:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070121342395329df8&s=b><strong>动脉网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Medtronic and Philips, two global leaders in healthcare technology, announced a significant step forward in their strategic collaboration in patient monitoring, signing a multi-year partnership ...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070121342395329df8&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0072461881.USD","symbol_name":"BGF US BASIC VALUE \"A2\" ACC","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070121342395329df8&s=b","article_id":"2548023640","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070121342395329df8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2548023640","pubTimestamp":1751376660,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"Medtronic and Philips, two global leaders in healthcare technology, announced a significant step forward in their strategic collaboration in patient monitoring, signing a multi-year partnership agreement focused on improving patient care and expanding access to technology.医疗技术领域的两大全球领导者美敦力和飞利浦宣布，他们在患者监护方面的战略协作取得了重要进展，签署了一项多年合作伙伴协议，重点关注改善患者护理并扩大技术的获取途径。Medtronic and Philips have a strong history of partnership in monitoring since 1992 and continue to work together to provide combined leading technologies for individual monitoring parameters.自 1992 年以来，美敦力和飞利浦在监护方面有着长期的合作历史，并继续共同努力为个人监护参数提供组合领先的技术。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0072461881.USD":"BGF US BASIC VALUE \"A2\" ACC","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","LU2271345857.HKD":"ALLIANZ GLOBAL SUSTAINABILITY \"AT\" (HKD) ACC","LU1291159041.SGD":"CPR Invest - Global Silver Age A2 Acc SGD-H","IE00BQXX3F31.USD":"GUINNESS GLOBAL INNOVATORS \"C\" (USD) ACC","LU0314106906.USD":"MANULIFE GF GLOBAL EQUITY \"AA\" (USD) INC","MDT":"美敦力","LU2023251221.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"AM\" (USD) INC","LU2111349929.HKD":"ALLIANZ GLOBAL SUSTAINABILITY \"AM\" (HKD) INC","BK4588":"碎股","LU0211326839.USD":"TEMPLETON GLOBAL INCOME \"A\" (USD) INC","LU0320765489.SGD":"FTIF - Franklin Mutual US Value A Acc SGD","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","LU0496365809.HKD":"TEMPLETON GLOBAL INCOME \"A\" (HKD) INC (Q)","IE000M9KFDE8.USD":"NEUBERGER BERMAN US LARGE CAP VALUE \"A\" (USD) ACC","LU0211331839.USD":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","LU0211326755.USD":"TEMPLETON GLOBAL INCOME \"A\" (USD) ACC","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","LU0158827948.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"A\" (USD) INC","LU0265550359.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A2\" (USD) ACC","LU1989764664.SGD":"CPR Invest - Global Disruptive Opportunities A2 Acc SGD-H","LU2028103732.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"AMG\" (USD) INC","IE00BFXG1179.USD":"BNY MELLON U.S. EQUITY INCOME \"B\" (USD) INC","LU0158827781.USD":" ALLIANZ GLOBAL SUSTAINABILITY \"AT\" (USD) ACC","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","BK4082":"医疗保健设备","LU1989764748.USD":"东方汇理环球颠覆性机遇A2 Acc","LU2089283258.USD":"安联环球可持续基金Cl AM Dis","LU2112291526.USD":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","LU1116320737.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A6\" (USD) INC","LU0265550946.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A5\" (USD) INC","LU0976567544.SGD":"FTIF - Templeton Global Income A Mdis SGD-H1","LU1506573853.SGD":"MANULIFE GF GLOBAL EQUITY \"AA\" (SGD) INC","BK4585":"ETF&股票定投概念","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU0122379950.USD":"贝莱德世界健康科学A2","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","IE00B3T34201.USD":"BNY MELLON GLOBAL EQUITY INCOME \"B\" (USD) INC","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","BK4566":"资本集团","IE00BQXX3D17.EUR":"GUINNESS GLOBAL INNOVATORS \"C\" (EUR) ACC","PHG":"飞利浦","LU2089284900.SGD":"Allianz Global Sustainability Cl AM Dis H2-SGD","IE00BQXX3C00.GBP":"GUINNESS GLOBAL INNOVATORS \"C\" (GBP) ACC","LU0162691827.USD":"BGF US BASIC VALUE \"A4\" INC","LU1116320901.HKD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A6\" (HKD) INC","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC"},"translate_title":"Medtronic Announces Strategic Partnership with Philips to Expand Use of Patient Monitoring Technology Medtronic announces strategic partnership with Philips to expand access to patient monitoring technology","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PHG":1,"MDT":1},"content_text":"Medtronic and Philips, two global leaders in healthcare technology, announced a significant step forward in their strategic collaboration in patient monitoring, signing a multi-year partnership agreement focused on improving patient care and expanding access to technology.医疗技术领域的两大全球领导者美敦力和飞利浦宣布，他们在患者监护方面的战略协作取得了重要进展，签署了一项多年合作伙伴协议，重点关注改善患者护理并扩大技术的获取途径。Medtronic and Philips have a strong history of partnership in monitoring since 1992 and continue to work together to provide combined leading technologies for individual monitoring parameters.自 1992 年以来，美敦力和飞利浦在监护方面有着长期的合作历史，并继续共同努力为个人监护参数提供组合领先的技术。The new strategic partnership agreement includes the integration of next-generation technologies from Medtronic into Philips’ monitoring solutions, providing a streamlined offering for healthcare providers. Philips' patient monitoring systems currently incorporate world-class Medtronic technology, including Nellcor™ pulse oximetry, Microstream™ capnography, and BIS™ brain monitoring.新的战略合作协议包括将美敦力的下一代技术整合到飞利浦的监测解决方案中，为医疗保健提供者提供简化的服务。飞利浦的患者监测系统目前集成了世界级的美敦力技术，包括Nellcor™脉搏血氧饱和度监测、Microstream™二氧化碳图和BIS™脑监测。Under the new agreement, Philips will also bundle its essential supplies, including ECG, NIBP, and batteries, with Philips’ Medtronic-enabled monitors. This combined offering helps better meet the needs of clinicians around the globe through expanded equipment access to the latest technology and through joint training and education programs designed to improve patient care..根据新协议，飞利浦还将把其重要耗材（包括心电图、无创血压和电池）与其支持美敦力的监护仪捆绑在一起。这一组合产品通过扩大对最新技术设备的使用权限，以及通过旨在改善患者护理的联合培训和教育项目，更好地满足了全球临床医生的需求。Reinforcing their dedication to high-quality, safe monitoring, the two companies are also establishing a pledge program. Both organizations believe using products that have been rigorously validated and tested on both parties' equipment is essential for ensuring patient safety.两家公司还建立了宣誓计划，以加强他们对高质量、安全监测的承诺。这两个组织都认为，使用在双方设备上经过严格验证和测试的产品，对确保患者安全至关重要。“We’re proud to strengthen our collaboration with Medtronic, a partner that shares our commitment to expanding access to safe, reliable patient care,” said Sachin Chaudhari, vice president and general manager, Clinical Applications and Devices, Philips Hospital Patient Monitoring. “By providing a comprehensive monitoring solution that is validated throughout all stages, we’re supporting clinicians’ heavy workloads and complex patient cases by providing tools that can help address the daily challenges care teams face.”.“我们很高兴加强与美敦力的合作，这是一个与我们一样致力于扩大安全、可靠的患者护理渠道的合作伙伴，”飞利浦医院患者监护部门临床应用和设备副总裁兼总经理萨钦·查哈里表示。“通过提供一个在各个阶段都经过验证的全面监测解决方案，我们为临床医生繁重的工作量和复杂的患者病例提供了支持，这些工具可以帮助应对护理团队面临的日常挑战。”With a shared commitment to enhancing patient care, the continued innovation that Medtronic is delivering — coupled with Philips’ market-leading monitoring solutions — will provide clinicians, patients, and caregivers greater insights and reliable monitoring.通过共同致力于提升患者护理，美敦力持续带来的创新与飞利浦市场领先的监测解决方案相结合，将为临床医生、患者和护理人员提供更深入的洞察和可靠的监测。“Together with Philips, we are eager to continue to integrate next-generation technologies and leverage our combined global presence to empower healthcare professionals with world-class technology to personalize patient care, anytime, anywhere,” said Brian Blomerth, vice president of strategy operations and chief financial officer for the Acute Care & Monitoring business, which is part of the Medical Surgical Portfolio at Medtronic.“我们与飞利浦一起，渴望继续整合下一代技术，利用我们共同的全球影响力，为医疗专业人员提供世界级的技术，以随时随地个性化患者护理。”美敦力外科手术产品组合中急性护理和监测业务的战略运营副总裁兼首席财务官布莱恩·布洛梅斯说道。“The patient monitoring technology from Philips already incorporates the market-leading Medtronic brands of Nellcor™ pulse oximetry, Microstream™ capnography, and BIS™ brain monitoring, and building on this foundation exemplifies our dedication to advancing innovation and enhancing patient care.”.“飞利浦的患者监测技术已经融合了市场领先的美敦力旗下Nellcor™脉搏血氧仪、Microstream™呼气末二氧化碳监测和BIS™脑部监测品牌，而在此基础上进一步发展则体现了我们对推动创新和提升患者护理的承诺。”About Philips关于飞利浦Royal Philips is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home..皇家飞利浦是一家领先的健康技术公司，致力于通过有意义的创新来改善人们的健康和福祉。飞利浦以患者和人民为中心的创新利用先进技术，并结合深入的临床和消费者洞察，为消费者提供个人健康解决方案，为医疗机构及其患者提供专业的健康解决方案，涵盖医院和家庭场景。Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. In 2023, Philips generated sales of EUR 18.2 billion and employs approximately 69,100 employees with sales and services in more than 100 countries.总部位于荷兰的飞利浦是诊断影像、超声、影像引导治疗、患者监护和企业信息化以及个人健康领域的领导者。2023年，飞利浦的销售额达到182亿欧元，在全球100多个国家拥有约69,100名员工，负责销售和服务。News about Philips can be found at .有关飞利浦的新闻可以在找到。www.philips.com/newscenterwww.philips.com/newscenter.。About Medtronic美敦力公司简介Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries.大胆思考。更果敢的行动。我们是美敦力。美敦力公司总部位于爱尔兰戈尔韦，是全球领先的医疗技术公司，通过寻找和发现解决方案，勇敢地应对人类面临的最严峻的健康问题。我们的使命——减轻病痛、恢复健康、延长生命——将遍布150多个国家的95,000多名充满热情的员工团结在一起。Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day.我们的技术和疗法治疗70种健康状况，包括心脏设备、手术机器人、胰岛素泵、手术工具、患者监测系统等。凭借我们广泛的知识、永无止境的好奇心和帮助所有需要帮助的人的愿望，我们提供创新技术，每秒、每小时、每一天都在改变两个人的生活。Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic, visit .随着我们推动以洞察力为导向的护理、以人为本的体验以及为我们的世界带来更好的结果，期待我们做得更多。在我们所做的一切中，我们正在创造非凡。欲了解有关美敦力的更多信息，请访问。medtronic.com美敦力官网and follow Medtronic on并关注美敦力LinkedIn领英.。Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.任何前瞻性陈述都受到风险和不确定性的影响，例如美敦力公司向证券交易委员会提交的定期报告中描述的那些。实际结果可能与预期结果有重大差异。Contacts:联系人：Pamela Lee帕梅拉·李Communications通讯+1-303-218-8264+1-303-218-8264Ryan Weispfenning瑞安·魏斯芬宁Investor Relations投资者关系+1-763-505-4626+1-763-505-4626","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2548023640","isCrawlerRequest":true}